Email this article The use of ronkolejkinin the complex therapyof the patientswith a relapseof HBeAg-negative chronic hepatitis B
- Authors: Melnikova EA1
-
Affiliations:
- Issue: Vol 10, No 3-4 (2010)
- Pages: 57-61
- Section: Articles
- URL: https://aspvestnik.ru/2410-3764/article/view/25049
- DOI: https://doi.org/10.17816/2072-2354.2010.0.3-4.57-61
- ID: 25049
Cite item
Full Text
Abstract
The article discusses the results of a comprehensive treatment of patients with a relapse of HBeAg-negative chronic hepatitis В. Presented using ;ronkolejkin in combination with lamivudine in this category of patients. Submissions studies indicate high efficiency destination this regimen for normalization of major clinical and biochemical and immunological indicators, repeat the patients with chronic hepatitis B.
References
- Шахгильдян И.В., Михайлов М.И. Эпидемиология вирусных гепатитов. Доклад на XII Российской конференции «Гепатология сегодня» 27 марта 2006 г.
- Kao J.I., Chen D.S. Global control of hepatic B virus infection. Lancet Infect. Dis., 2002, 2, 395-403.
- Lau J.Y., Wright T.L. Molecular virology and pathogenesis of hepatitis B. Lancet, 1993, 342, 1335-1340.
Supplementary files
